Pharmafile Logo
Pharmafocus logo
Advanced Search

Research and Development

Showing 15 posts of 9573 posts found.

Chiltern Acquires Brazil-based Clinical Research Organization Vigiun

December 7, 2009 Research and Development

Chiltern International Limited (Chiltern), a global Clinical Research Organization (CRO) providing clinical development and staffing services in Europe, the Americas …
News
Press release
Leeds

Process R&D lab brings academia and industry together

December 3, 2009 Research and Development Leeds, chemicals

A newly-opened laboratory at the University of Leeds in the UK will help support the development of ‘greener, cheaper and …
News
p-010398-04-18

Call for Europe-wide innovation fund

December 3, 2009 Research and Development Europe, biotech, finance

A new report on the state of biotech and pharmaceutical R&D in Europe says the sector is suffering from a …
News
Dalli

EU shake up for pharma

December 2, 2009 Research and Development, Sales and Marketing Commission, Europe

 Responsibility for pharma and biotech policy has been taken away from the European Commission’s Enterprise and Industry directorate and handed to the …
News

Bayer takes Alzheimer’s diagnostic into pivotal trials

December 2, 2009 Research and Development Alz, Bayer, diagnostic

An imaging agent that can detect amyloid plaques in the brains of Alzheimer’s patients and so may provide an accurate …
News

Oxford BioTherapeutics appoints Dr Jim Cornett, Dr Jon Terrett and Dr Mike Gresser

December 2, 2009 Research and Development Oxford Biotherapeutics, appointment, research and development

Oxford BioTherapeutics has expanded its US operations, recruiting a number of senior industry leaders.Dr Jim Cornett will head up operations …
Appointment

New deal supports French pharma and biotech

December 1, 2009 Research and Development, Sales and Marketing France, biotech

 The French government has agreed a new deal with industry leaders to help the country’s pharma and biotech industries.President Sarkozy …
News

PPD buys BioDuro to get bigger in China

December 1, 2009 Research and Development CRO, China, em

Pharmaceutical Product Development (PPD) has expanded its capacity to offer drug development services in Asia once again with the acquisition …
News

Building value – is the pipeline all that matters?

December 1, 2009 Research and Development Les Rose, biotech, venture capital

Venture capital is a curious business and the global financial crisis in which we find ourselves has exposed some rather …
Feature

Incyte’s Novartis cancer drug deal could be worth $1bn

December 1, 2009 Research and Development Incyte, Novartis

Novartis has paid Incyte Corporation $150 million up front for the rights to two oral investigational hematology-oncology therapies.The first is …
News
ExonHit-Therapeutics-Herve100

Hervé Duchesne de Lamotte, chief financial officer, ExonHit Therapeutics

December 1, 2009 Research and Development ExonHit Therapeutics, appointment, research and development

ExonHit Therapeutics appoints Hervé Duchesne de Lamotte chief financial officer.The Paris-based company develops innovative molecular diagnostic tests and therapeutics for …
Appointment

GSK licences smoking vaccine candidate

November 30, 2009 Research and Development GSK, Nabi, smoking, vaccines

GlaxoSmithKline Biologicals has signed a licensing agreement for a nicotine vaccine candidate currently in the first of two phase III …
News

Clinical research news in brief

November 30, 2009 Research and Development CRO, Clinipace, ICON, Parexel

Pharmafocus’ latest round-up of clinical research news includes a new US registry to aid patient recruitment, alliances for ICON, Parexel …
News

EMA: Aligning regulation with the lifecycle of medicines

November 30, 2009 Research and Development EMA, EMEA, Thomas Lönngren, regulatory affairs

The European Agency for the Evaluation of Medicinal Products was set up in 1995 in London’s Docklands, an isolated eastern …
Feature

Roche invests in Spanish genome project

November 27, 2009 Research and Development Roche, Spain, genomics

Roche is investing in a Spanish health authority programme to analyse the genomes of people with rare diseases.The pharma company …
News
The Gateway to Local Adoption Series

Latest content

STADA and Bio-Thera’s Gotenfia receives positive CHMP opinion for autoimmune diseases

December 18, 2025

Norgine enters exclusive licensing agreement with Vir Biotechnology

December 18, 2025

Incyclix appoints Kimberly Blackwell to Board of Directors

December 17, 2025

Hansa Biopharma appoints Max Sakajja as Vice President, General Manager Europe and International

December 17, 2025

GSK’s Exdensur receives MHRA approval for asthma and rhinosinusitis

December 16, 2025